2025-08-04Niranjan Ghatule
Russia is on the brink of a medical breakthrough with the launch of the world’s first personalized cancer vaccine developed by the Gamaleya Research Institute. Using AI and mRNA technology, this custom-made vaccine targets melanoma and promises faster, more effective cancer treatment tailored to each patient. Trials begin soon, with global collaboration already on the horizon
View more
Your experience on this site will be improved by allowing cookies
Cookie Policy
